[Epidemiology of Chronic Kidney Disease - Ever More Patients?]

Insights

Methodological challenges in measuring kidney function and disease epidemiology are discussed. Despite these issues, global chronic kidney disease (CKD) prevalence may be declining, contrary to some expectations.

Area of Science:

  • Nephrology
  • Epidemiology
  • Public Health

Background:

  • Chronic kidney disease (CKD) is a common complication of diabetes, obesity, hypertension, and heart failure.
  • Accurate measurement of kidney function and disease epidemiology faces significant methodological challenges.
  • CKD is defined by reduced glomerular filtration rate, anatomical lesions, and duration exceeding three months.

Purpose of the Study:

  • To review methodological pitfalls in measuring kidney function.
  • To examine challenges in determining the epidemiology of kidney disease.
  • To analyze trends and future projections of CKD prevalence.

Main Methods:

  • Review of existing literature on kidney function measurement and CKD epidemiology.
  • Analysis of data from large-scale studies like the Global Burden of Disease Study.
  • Examination of German epidemiological data, noting limitations due to lack of a national register.

Main Results:

  • Estimating glomerular filtration rate (GFR) using serum creatinine or cystatin C is influenced by extrarenal factors.
  • Anatomical lesions and disease duration are rarely assessed in epidemiological studies.
  • Global CKD prevalence may be declining, with German cross-sectional studies showing 6-26% prevalence.

Conclusions:

  • Improved risk factor control may reduce CKD incidence.
  • Stable prevalences are expected due to better medical care and survival.
  • The long-term increase in CKD patient numbers is not anticipated.

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
832
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
503
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
760
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
268
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.0K
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
447